Impact of drug diversity on treatment effectiveness in relapsing-remitting multiple sclerosis (RRMS) in Germany between 2010 and 2018: real-world data from the German NeuroTransData multiple sclerosis registry

OBJECTIVE: To evaluate the impact of drug diversity on treatment effectiveness in relapsing-remitting multiple sclerosis (RRMS) in Germany. DESIGN: This study employs real-world data captured in-time during clinical visits in 67 German neurology outpatient offices of the NeuroTransData (NTD) multipl...

Descripción completa

Detalles Bibliográficos
Autores principales: Braune, Stefan, Rossnagel, Fabian, Dikow, Heidi, Bergmann, Arnfin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336188/
https://www.ncbi.nlm.nih.gov/pubmed/34344670
http://dx.doi.org/10.1136/bmjopen-2020-042480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336188/
https://www.ncbi.nlm.nih.gov/pubmed/34344670
http://dx.doi.org/10.1136/bmjopen-2020-042480

Ejemplares similares